Showing results (301-310 of 315) with videos related to

Sort By:
Pageof 32
Annals of the New York Academy of Sciences|July 18, 2002
The role of cyclic AMP and its effect on protein kinase A in the mitogenic action of thyrotropin on the thyroid cellS Dremier, K Coulonval, S Perpete, et al.
Annales D'Endocrinologie|August 12, 2003
[Pilot study and preliminary validation of the French version of a quality-of-life questionnaire specific for subjects with growth hormone deficiency]A Leplège, E Ecosse, F Archambau, et al.
Cell Death and Differentiation|March 2, 2013
p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathwayM Farhang Ghahremani, S Goossens, D Nittner, et al.
European Journal of Endocrinology|December 22, 1999
GH deficiency in adults: an epidemiological approachG Sassolas, F B Chazot, P Jaquet, et al.
World Journal of Surgery|September 1, 1996
Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine SurgeonsJ L Kraimps, A Denizot, B Carnaille, et al.
Histopathology|March 26, 2003
Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS studyA Vincent-Salomon, G MacGrogan, J Couturier, et al.
International Journal of Molecular Sciences|June 26, 2025
Dysregulation of Inositol Polyphosphate 5-Phosphatase OCRL in Alzheimer's Disease: Implications for Autophagy DysfunctionKunie Ando, May Thazin Htut, Eugenia Maria Antonelli, et al.
EMBO Molecular Medicine|June 2, 2017
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclibEric Raspé, Katia Coulonval, Jaime M Pita, et al.
Molecular Oncology|December 1, 2022
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibitionSabine Paternot, Eric Raspé, Clément Meiller, et al.
Frontiers in Endocrinology|November 15, 2023
CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomasJaime M Pita, Eric Raspé, Katia Coulonval, et al.
Pageof 32